Register for your free account and gain access to your "My ETFs" watch list. Located on the top panel of the Horizons ETFs website, "My ETFs" allows you to conveniently view pricing and NAV information about selected ETFs across all of your devices. All personal information is secure and will not be shared.
HMMJ $6.64
Change $-0.03 -0.45%
Volume 440089
Last Close $6.67
Prices delayed by 15 minutes. Last trade: Mar 27, 2020 05:15 PM
Ticker:
Inception Date:
NET ASSETS:
Consolidated Prior Day Volume:
Average Daily Trading Volume Over a 12 Month Period:
Exchange:
Investment Manager:
Eligibility:
Benchmark:
Bloomberg Index Ticker:
Management Fee:
Currency:
LEI:
HMMJ
April 04, 2017
331,082,497 (as at 2020-03-27)
922,259 (for 2020-03-27)
675,635 (as at 2020-02-29)
Toronto Stock Exchange
Horizons ETFs Management (Canada) Inc.
All Registered and Non-Registered Accounts
North American Marijuana Index
NAMMAR
0.75% (plus applicable sales tax)
CAD
549300M4MXEKBRHXKA74
Found In
Benchmark
Thematic Equity
Horizons Marijuana Life Sciences Index ETF (“HMMJ” or “ETF”) seeks to replicate, to the extent possible, the performance of the North American Marijuana Index (the “Index”), net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry.
By clicking subscribe, you are voluntarily subscribing to receive, and authorizing Horizons ETFs to email you, information on our Marijuana ETFs and related topics. You can withdraw consent at any time through a link found at the bottom of every email we send.
**Performance since inception on April 04, 2017, as at February 29, 2020
as at March 20, 2020
Holdings are subject to change. Download full prior week holdings.
Most Recent Distribution per Unit : 0.26847
Estimated Annualized Yield : 16.14%
12-Month Trailing Yield: 15.07%
Distribution Frequency : Quarterly
Record Date: 2020-03-31
Nav/Unit: $6.65360
Price: $6.64
Premium Discount: $-0.01
Premium Discount Percentage: -0.20%
Outstanding Shares: 49,760,180
as at March 27, 2020
• Strong growth potential: The North American marijuana market posted USD $6.7 billion in revenues in 2016; up 30% from the previous year* • Diversified exposure: Unlike an investment in the stock of a single marijuana company, HMMJ provides exposure to a diversified group of companies within the industry, reducing single security risk • Limited constraints: HMMJ will not invest in any constituent issuers that are primarily focused on serving the medical or recreational marijuana market in the United States, or the recreational marijuana market in Canada, unless and until such time as it becomes legal. HMMJ’s investment strategy permits the ETF to invest in marijuana companies which derive some portion of their revenue, currently or in the future, from the medical and/or recreational cannabis industry in certain U.S. states where cannabis use has been legalized by state law, notwithstanding that the use, possession, sale, cultivation and transportation of cannabis remains illegal under U.S. federal law • Rebalanced quarterly: The marijuana industry is rapidly growing and evolving. Quarterly rebalances seek to ensure the composition of HMMJ reflects the changing leadership and drivers of growth within the industry
* Source: Arcview Market Research (www.arcviewmarketresearch.com), March 2017.
The Horizons ETFs are listed on the Toronto Stock Exchange pursuant to prospectuses filed with Canadian regulators, in accordance with Canadian securities laws and regulations. None of the exchange traded funds managed by Horizons ETFs Management (Canada) Inc. are regulated by nor registered with the U.S. Securities and Exchange Commission (SEC), or with any other foreign regulatory body. Generally, non-residents of Canada, including U.S. residents, may invest through a local broker in their jurisdiction that has facilities for directly or indirectly executing orders on the Toronto Stock Exchange.
However, at no time may non-residents of Canada be the beneficial owners of a majority of the Units of any one of our ETFs. If at any point the Manager expects or believes that more than 40% of the Units of an ETF are beneficially held by non-residents, the Manager may elect to send notice to one or more such non-resident holders requiring them to sell all or a portion of their units of such ETF within a stated period of time. If such Units have not been sold within the stated period of time, the Manager will suspend the voting and distribution rights associated with those Units and sell the Units on the holders behalf. The rights of affected holders in such instance are limited to receiving the net proceeds of the sale of such Units.
This website uses cookies to ensure we give you the best experience. By continuing to browse the site, you are agreeing to our use of cookies. Click here to read our privacy policy.
Commissions, management fees and expenses all may be associated with an investment in exchange traded products managed by Horizons ETFs Management (Canada) Inc. (the "Horizons Exchange Traded Products"). The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing. The Horizons Exchange Traded Products include our BetaPro products (the “BetaPro Products”). The BetaPro Products are alternative mutual funds within the meaning of National Instrument 81-102 Investment Funds, and are permitted to use strategies generally prohibited by conventional mutual funds: the ability to invest more than 10% of their net asset value in securities of a single issuer, to employ leverage, and engage in short selling to a greater extent than is permitted in conventional mutual funds. While these strategies will only be used in accordance with the investment objectives and strategies of the BetaPro Products, during certain market conditions they may accelerate the risk that an investment in sahres of a BetaPro Product decreases in value. The BetaPro Products consist of our 2x Daily Bull and 2x Daily Bear ETFs (“2x Daily ETFs”), Inverse ETFs (“Inverse ETFs”) and our BetaPro S&P 500 VIX Short-Term Futures™ ETF (the “VIX ETF”). Included in the 2x Daily ETFs and the Inverse ETFs are the BetaPro Marijuana Companies 2x Daily Bull ETF (“HMJU”) and BetaPro Marijuana Companies Inverse ETF (“HMJI”), which track the North American MOC Marijuana Index (NTR) and North American MOC Marijuana Index (TR), respectively. The 2x Daily ETFs and certain other BetaPro Products use leveraged investment techniques that can magnify gains and losses and may result in greater volatility of returns. These BetaPro Products are subject to leverage risk and may be subject to aggressive investment risk and price volatility risk, among other risks, which are described in their respective prospectuses. Each 2x Daily ETF seeks a return, before fees and expenses, that is either 200% or –200% of the performance of a specified underlying index, commodity futures index or benchmark (the “Target”) for a single day. Each Inverse ETF seeks a return that is –100% of the performance of its Target. Due to the compounding of daily returns a 2x Daily ETF’s or Inverse ETF’s returns over periods other than one day will likely differ in amount and, particularly in the case of the 2x Daily ETFs, possibly direction from the performance of their respective Target(s) for the same period. Hedging costs charged to BetaPro Products reduce the value of the forward price payable to that ETF. Due to the high cost of borrowing the securities of marijuana companies in particular, the hedging costs charged to HMJI are expected to be material and are expected to materially reduce the returns of HMJI to unitholders and materially impair the ability of HMJI to meet its investment objectives. Currently, the manager expects the hedging costs to be charged to HMJI and borne by unitholders will be between 10.00% and 45.00% per annum of the aggregate notional exposure of HMJI’s forward documents. The hedging costs may increase above this range. The manager will publish, on its website, the updated monthly fixed hedging cost for HMJI for the upcoming month as negotiated with the counterparty to the forward documents, based on the then current market conditions. The VIX ETF, which is a 1x ETF, as described in the prospectus, is a speculative investment tool that is not a conventional investment. The VIX ETF’s Target is highly volatile. As a result, the VIX ETF is not intended as a stand-alone long-term investment. Historically, the VIX ETF’s Target has tended to revert to a historical mean. As a result, the performance of the VIX ETF’s Target is expected to be negative over the longer term and neither the VIX ETF nor its target is expected to have positive long-term performance. Investors should monitor their holdings in BetaPro Products and their performance at least as frequently as daily to ensure such investment(s) remain consistent with their investment strategies. *The indicated rates of return are the historical annual compounded total returns including changes in per unit value and reinvestment of all dividends or distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The rates of return shown in the table are not intended to reflect future values of the ETF or returns on investment in the ETF. Only the returns for periods of one year or greater are annualized returns.